MD Stock Analysis: Buy, Sell, or Hold?
MD - Pediatrix Medical Group, Inc.
$23.52
-0.09 (-0.38%)
▼
5d:
-3.21%
30d:
+4.67%
90d:
+19.39%
BUY
MODERATE Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Aug 04, 2026
Get Alerted When MD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: MD shows positive signals but monitor for confirmation. Market pricing in 1.4% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: MD shows positive signals but monitor for confirmation. Market pricing in 1.4% annual growth which appears achievable. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$27.36
Based on 3.9% avg growth
INTRINSIC VALUE TODAY
$16.99
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: MD is currently trading at $23.52, which is considered slightly high relative to its 30-day fair value range of $21.69 to $23.69. The stock's valuation (Forward PE: 10.0) is in line with its historical norms (9.6). At these levels, the market is pricing in 1.4% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, MD is in a uptrend. The price is approaching resistance at $23.71. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: MD has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, MD is in a uptrend. The price is approaching resistance at $23.71. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: MD has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$21.69 -
$23.69
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
72.4%
All Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($23.17)
- NEUTRAL: Market pricing in 1.4% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$21.69 -
$23.69
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$21.16
Resistance Level
$23.71
Current Trend
Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
9.97
Wall Street Target
$23.17
(-1.5%)
Revenue Growth (YoY)
3.9%
Earnings Growth (YoY)
50.0%
Profit Margin
9.0%
Valuation Premium vs History
+1.4% premium
PE vs Historical
10.0 vs 9.6
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+1.4%
(market-implied from PE analysis)
1-Year Target
$23.85
(+1%)
2-Year Target
$24.18
(+3%)
3-Year Target
$24.52
(+4%)
3-Yr Target (if PE normalizes)
(PE: 10→10)
PE COMPRESSION
$23.62
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 3.7%)
$57.24
(+143%)
Base:
(SPY PE: 10.0, Growth: 3.7%)
$26.20
(+11%)
Bear:
(PE: 8.5, Growth: 3.7%)
$22.27
(-5%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (11x PE), but valuation improves significantly next year (10x PE) as earnings recover.
Trailing PE: 11.46 | Current EPS (TTM): $2.06
Bull Case
$29.75
(+27%)
Analyst growth 14.5%, PE expands to 12.6
Base Case
$27.04
(+15%)
Market implied 14.5%, PE stable at 11.5
Bear Case
$16.05
(-32%)
Severe decline -20.0%, PE contracts to 9.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: June 23, 2026 9:01 AM ET
Data refreshes hourly during market hours. Next update: 10:01 AM
Data refreshes hourly during market hours. Next update: 10:01 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$244 | 57 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$504 | 60 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 53 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$22 | 54 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$133 | 58 HOLD |
